Internal Medicine, Pulmonary Disease · Brooklyn, NY
NPI
1548262348
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2000 Ocean Ave
Brooklyn, NY, 11230
Phone (718) 676-1028
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
1,415 services
Medicare patients, 2024
205
Average age 75
Drug cost, 2024
$757K
1,113 prescriptions
Company payments, 2025
$13K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chaim J Bernstein was code 99214 (office e&m - established), 443 times for 163 patients. In total Chaim J Bernstein billed 1,415 services in 18 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 443 | 163 | $110.24 | $49K |
| 94664 E&M - Miscellaneous | Office | 332 | 130 | $16.68 | $5,538 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 180 | 66 | $28.25 | $5,086 |
| 94060 Pulmonary Function Testing | Office | 133 | 85 | $35.12 | $4,671 |
| 94010 Pulmonary Function Testing | Office | 127 | 88 | $24.65 | $3,130 |
| 99205 Office E&M - New | Office | 82 | 82 | $194.58 | $16K |
| 94375 Pulmonary Function Testing | Office | 41 | 38 | $35.34 | $1,449 |
By year: 2022 $87K for 1,374 services; 2023 $104K for 1,772 services; 2024 $90K for 1,415 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chaim J Bernstein prescribed most often to Medicare patients was Bevespi Aerosphere (Glycopyrrolate/Formoterol Fum), with 100 prescriptions and refills. In total Chaim J Bernstein wrote 1,113 Medicare prescriptions that cost $757K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Bevespi Aerosphere Glycopyrrolate/Formoterol Fum | 100 | 122 | 25 | $48K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 98 | 138 | 35 | $3,318 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 76 | 134 | 27 | $82K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 67 | 108 | 18 | $67K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 57 | 73 | 22 | $9,848 |
| Fluticasone Propionate Generic | 42 | 62 | 13 | $574 |
| Prednisone Generic | 37 | 51 | 22 | $94.77 |
| Montelukast Sodium Generic | 34 | 100 | 14 | $478 |
| Ofev Nintedanib Esylate | 32 | 32 | Under 11 | $342K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 28 | 51 | 11 | $23K |
| Breyna Budesonide/Formoterol Fumarate | 26 | 38 | 12 | $5,826 |
| Ipratropium Bromide Generic | 26 | 30 | Under 11 | $994 |
| Azelastine Hcl Generic | 24 | 36 | 11 | $656 |
| Breo Ellipta Fluticasone/Vilanterol | 24 | 34 | Under 11 | $12K |
| Amlodipine Besylate Generic | 23 | 67 | Under 11 | $166 |
Brand drugs: 579 claims; generic drugs: 534 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chaim J Bernstein $13K ($13K in general payments such as food, travel and fees) from 13 companies. The largest payer was Verona Pharma, Inc. with $9,435.
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. VRNA | 28 | $9,435 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $2,169 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $516 |
| Genzyme Corporation SNY | 6 | $269 |
| Insmed, Inc. INSM | 14 | $246 |
| Medtronic, Inc. MDT | 2 | $186 |
| GlaxoSmithKline, LLC. GSK | 10 | $148 |
| Mallinckrodt Hospital Products Inc. | 1 | $143 |
| Viatris Specialty LLC | 4 | $104 |
| Electromed, Inc. ELMD | 8 | $90.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.